These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2503055)

  • 21. GABA transaminase inhibitors enhance the release of endogenous GABA but decrease the release of beta-alanine evoked by electrical stimulation of slices of the rat medulla oblongata.
    Kihara M; Misu Y; Kubo T
    Life Sci; 1988; 42(19):1817-24. PubMed ID: 2897054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substrate inhibition of D-amino acid transaminase and protection by salts and by reduced nicotinamide adenine dinucleotide: isolation and initial characterization of a pyridoxo intermediate related to inactivation.
    van Ophem PW; Erickson SD; Martinez del Pozo A; Haller I; Chait BT; Yoshimura T; Soda K; Ringe D; Petsko G; Manning JM
    Biochemistry; 1998 Mar; 37(9):2879-88. PubMed ID: 9485439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of GABA-transminase inhibition on rectal temperature in mice.
    Schechter PJ; Tranier Y
    Pharmacol Biochem Behav; 1977 Jun; 6(6):667-9. PubMed ID: 263549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. gamma-Acetylenic GABA in tardive dyskinesia.
    Casey DE; Gerlach J; Magelund G; Christensen TR
    Arch Gen Psychiatry; 1980 Dec; 37(12):1376-9. PubMed ID: 6108751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The action of gamma-vinyl-GABA and gamma-acetylenic-GABA on the resting and stimulated release of GABA in vivo.
    Abdul-Ghani AS; Coutinho-Netto J; Bradford HF
    Brain Res; 1980 Jun; 191(2):471-81. PubMed ID: 7378767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of 4-amino hex-5-ynoic acid (gamma-acetylenic GABA, gammma-ethynyl GABA) a catalytic inhibitor of GABA transaminase, on brain GABA metabolism in vivo.
    Jung MJ; Lippert B; Metcalf BW; Schechter PJ; Böhlen P; Sjoerdsma A
    J Neurochem; 1977 Apr; 28(4):717-23. PubMed ID: 894280
    [No Abstract]   [Full Text] [Related]  

  • 27. Role reversal for substrates and inhibitors. Slow inactivation of D-amino acid transaminase by its normal substrates and protection by inhibitors.
    Bhatia MB; Martinez del Pozo A; Ringe D; Yoshimura T; Soda K; Manning JM
    J Biol Chem; 1993 Aug; 268(24):17687-94. PubMed ID: 8349653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of gamma-vinyl GABA on bicuculline-induced seizures.
    Kendall DA; Fox DA; Enna SJ
    Neuropharmacology; 1981 Apr; 20(4):351-5. PubMed ID: 7290349
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of gamma-vinyl GABA on food intake of rats.
    Huot S; Palfreyman MG
    Pharmacol Biochem Behav; 1982 Jul; 17(1):99-106. PubMed ID: 7122673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of a GABA transaminase inhibitor, gamma-vinyl GABA, on voluntary morphine consumption in the rat.
    Buckett WR
    Psychopharmacology (Berl); 1981; 75(2):214-6. PubMed ID: 6798609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection by 4-amino-hex-5-enoic acid (gamma-vinyl GABA) and hypobaric hypoxia against kainic acid neurotoxicity.
    Lenicque PM; Wepierre J; Cohen Y
    Psychopharmacology (Berl); 1979; 66(1):51-3. PubMed ID: 120542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical amelioration.
    Tell G; Böhlen P; Schechter PJ; Koch-Weser J; Agid Y; Bonnet AM; Coquillat G; Chazot G; Fischer C
    Neurology; 1981 Feb; 31(2):207-11. PubMed ID: 6258106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GABAergic mechanisms in morphine-induced hypothermia.
    Del Rio-Garcia J; Cremades A
    Eur J Pharmacol; 1990 Oct; 187(3):495-500. PubMed ID: 2073923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Irreversible inhibition of D-3-aminoisobutyrate-pyruvate aminotransferase by gabaculine.
    Kaneko M; Fujimoto S; Kikugawa M; Tamaki N
    FEBS Lett; 1990 Dec; 276(1-2):115-8. PubMed ID: 2125004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seizure protection and increased nerve-terminal GABA: delayed effects of GABA transaminase inhibition.
    Gale K; Iadarola MJ
    Science; 1980 Apr; 208(4441):288-91. PubMed ID: 6768130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereochemistry of the inactivation of 4-aminobutyrate: 2-oxoglutarate aminotransferase and L-glutamate 1-carboxylase by 4-aminohex-5-ynoic acid enantiomers.
    Danzin C; Claverie N; Jung MJ
    Biochem Pharmacol; 1984 Jun; 33(11):1741-6. PubMed ID: 6375677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effects of vigabatrin, gamma-acetylenic GABA, aminooxyacetic acid, and valproate on levels of various amino acids in rat brain regions and plasma.
    Löscher W; Hörstermann D
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Mar; 349(3):270-8. PubMed ID: 8208305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression by sodium valproate of gamma-vinyl GABA-induced facilitation of visual evoked potentials in rats.
    Myslobodsky MS; Morag M
    Electroencephalogr Clin Neurophysiol; 1981 Nov; 52(5):445-50. PubMed ID: 6171410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel D-amino acid transaminase.
    Aretz W; Sauber K
    Ann N Y Acad Sci; 1988; 542():366-70. PubMed ID: 3228235
    [No Abstract]   [Full Text] [Related]  

  • 40. Interrelationships between ornithine, glutamate, and GABA. II. Consequences of inhibition of GABA-T and ornithine aminotransferase in brain.
    Daune G; Seiler N
    Neurochem Res; 1988 Jan; 13(1):69-75. PubMed ID: 2897088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.